Overview

Defibrotide in Children With High Risk Kawasaki Disease

Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
This study evaluates the safety of defibrotide with IVIG in children with high risk Kawasaki disease.
Phase:
Phase 2
Details
Lead Sponsor:
New York Medical College
Collaborators:
Columbia University
Johns Hopkins University
New York University
Treatments:
Defibrotide